Clinical Trial Update: Bedside Testing of CYP2C19 Gene for Treatment of Patients With PCI With Antiplatelet Therapy [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update examining bedside CYP2C19 genetic testing to guide antiplatelet therapy in patients undergoing percutaneous coronary intervention …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Angina Pectoris
• Coronary Artery Disease
• Embolism
• Ischemia
• Myocardial Infarction
• Thrombosis

Drugs mentioned

• Aspirin (Aspirin)
• CLOPIDOGREL (CLOPIDOGREL)
• PRASUGREL (prasugrel)
• TICAGRELOR (ticagrelor)

Snippet

Sponsor: Imam Abdulrahman Bin Faisal University | Conditions: Coronary Artery Disease, Myocardial Infarction | Phase 4 | Status: UNKNOWN